by EpicentRx | Aug 10, 2023 | Blog
In solemn commemoration of the 78th anniversary of Hiroshima on August 6, 1945, and Nagasaki on August 9, 1945, when the first nuclear weapons were detonated, let us strengthen our resolve to never ever again use them. As Einstein famously said, “I know not with what...
by EpicentRx | Aug 9, 2023 | Blog
Just what is it about the algebraic letter X that serial entrepreneur and real-life X man, Elon Musk, likes so much? Hmm…let’s see…his son is named X Æ A-Xii, “X” for short and really thank goodness because how do you pronounce THAT???, one of his first ventures was...
by EpicentRx | Aug 7, 2023 | Blog
“Mary, Mary quite contrary, please expand your vocabulary.” Radiochemoprotection or Chemoradioprotection Variation. Radiochemopretection or Chemoradiopretection Definition: Noun: A term to describe the prevention or mitigation of the harmful effects of exposure to...
by EpicentRx | Aug 4, 2023 | Blog
The new International Nonproprietary Name (INN) for RRx-001 is nibrozetone (pronunciation: NA-ih-broh-tseh-TOH-uun). See blog post EpicentRx Word of the Week: NO and press release United States Adopted Name (USAN) Council and International Nonproprietary Names (INN)...
by EpicentRx | Aug 2, 2023 | Blog
We recently talked to a hedge fund manager, an obsessed scratch golfer, let’s call him Bill, because of how pricey he is, about the EpicentRx anticancer therapy, AdAPT-001. He asked us to explain AdAPT-001 to him in the simplest language possible, and to keep the...
